Inflammatory reactions induced by pretransplant conditioning—An alternative target for modulation of acute GvHD and Complications following allogeneic bone marrow transplantation?

Leukemia and Lymphoma

Volumn 25, Issue 42067, 1997, Pages 217-224

  Holler, E ^a,b   Ertl, B ^a,b   Hintermeier Knabe, R ^a,b   Roncarolo, M G ^c   Eissner, G ^d   Mayer, F ^a   Behrends, U ^d   Fraunberger, P ^d   Pfannes, W ^a,b   Kolb, H J ^a,b   Wilmanns, W ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c MERCK RESEARCH LABORATORIES   (United States)

^d InstfKlinische Chemie Klinikum Groj hadern   (Germany)

Author keywords

acute GvHD; allogeneic BMT; Conditioning regimens; cytokine antagonists; proinflammatory cytokines

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTOKINE; CYTOTOXIC AGENT; ENDOTOXIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; MONOCLONAL ANTIBODY MAK195F; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOGENETICS; INFLAMMATION; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WHOLE BODY RADIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; CLINICAL TRIALS; CYTOKINES; GRAFT VS HOST DISEASE; HUMANS; INFLAMMATION; TRANSPLANTATION CONDITIONING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 8244248792     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199709114161     Document Type: Article

References (35)

1. Clift R. A., Buckner C. D., Appelbaum F. R., Bearman S. I., Petersen F. B., Fisher L. D., Anasetti C., Beatty P., Bensinger W. I., Doney K., Hill R. S., McDonald G. B., Martin P., Sanders J., Singer J., Stewart P., Sullivan K. M., Witherspoon R., Storb R., Hansen J. A., Thomas E. D. Allogeneic Marrow Transplantation in Patients with acute myeloid leukemia in first remission: A randomized trial of two irradiation regimens. Blood 1990; 76 (9) 1867 – 1871
2. Deeg H. J., Spitzer T. R., Cottler-Fox M., Cahill R., Pickle L. W. Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/ cyclosporine prophylaxis. Bone Marrow Transplantation 1991; 7 (3) 193 – 198
3. Holler E., Kolb H. J., Moeller A., Kempeni J., Liesenfeld S., Pechumer H., Lehmacher W., Ruckdeschel G., Gleixner B., Riedner C., Ledderose G., Brehm G., Mittermueller J., Wilmanns W. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011 – 1016
4. Antin H. J., Ferrara J. L.M. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964 – 2968
5. Holler E., Kolb H. J., Hintermeier-Knabe R., Mittermüller J., Thierfelder S., Kaul M., Wilmanns W. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow trans-plantation. Transplant. Proc. 1993; 25 (1) 1234 – 1236
6. Remberger M., Ringden O., Markling L. TNFa levels are increased during bone marrow transplantation conditioning in patients who develop acute GvHD. Bone Marrow Transplantation 1995; 15: 99 – 104
7. Engelbeerts I., Stephens S., Francot G. J. M., Van der Linden C. J., Buurman W. A. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 1991; 338: 515 – 516
8. Holler E., Kolb H. J., Hintermeier-Knabe R., Kempeni J., Herve P., Moeller A., Wilmanns W. Systemic release of tumor necrosis factor alpha in human allogeneic bone marrow transplantation: Clinical risk factors, prognostic significance and therapeutic approaches, Berlin-Heidelberg. Cytokines in Hemopoiesis, Oncology and AIDS II. Eds. Freund/Link/Schmidt/Welte. Springer-Verlag. 1992; 435 – 442
9. Holler E., Kolb H. J., Mittermueller J., Kaul M., Ledderose G., Duell T., Seeber B., Schleuning M., Hintermeier-Knabe R., Ertl B., Kempeni J., Wilmanns W. Modulation of acute graft-versus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNFa) release in the course of pretransplant conditioning: Role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNFa (MAK195F). Blood 1995; 86: 890 – 899
10. Hallahan D. E., Spriggs D. R., Beckett M. A., Kufe D. W., Weichselbaum R. R. Increased tumor necrosis factor a mRNA after cellular exposure to ionizing irradiation. PNAS USA 1989; 88: 10104 – 10107
11. Sherman M. L., Datta R., Hallahan D. E., Weichselbaum R. R., Kufe D. W. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J. Clin. Invest. 1991; 87: 1794 – 1797
12. Hallahan D. E., Virudachalam S., Sherman M. L., Huberman E., Kufe D. W., Weichselbaum R. R. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res. 1991; 51 (17) 4565 – 4569
13. Hong J. H., Chiang C. S., Campbell I. L., Sun J. R., Withers H. R., McBride W. H. Induction of acute phase gene expression by brain irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1995; 33 (3) 619 – 626
14. Rubin P., Johnston C. J., Williams J. P., McDonald S., Finkelstein J. N. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int. J. Rod. Oncol. Biol. Phys. 1995; 33 (1) 99 – 109
15. Langberg C. W., Hauer-Jensen M., Sung C. C., Kane C. J. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother. Oncol. 1994; 32 (1) 29 – 36
16. Xun C. Q., Thompson J. S., Jennings C. D., Brown S. A., Widmer M. B. Effect of total body irradiation, busulfan-cyclophosphamide or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 1994; 83: 2360 – 2367
17. Niederwieser D., Herold M., Woloszczuk W., Aulitzky W., Meister B., Tilg H., Gastl G., Bowden R., Huber C. Endogenous IFN-gamma during human bone marrow transplantation. Transplantation 1990; 175: 620 – 625
18. Walsh J., Wheeler H. R., Geczy G. L. Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Br. J. Haematol. 1992; 81 (4) 480 – 488
19. Sodhi A., Pai K. Increased production of interleukin 1 and tumor necrosis factor by human monocytes treated in vitro with cisplatin or other biological response modifiers. Immunology Letters 1992; 34: 183 – 188
20. Peschel C., Aman M. J., Rudolf G., Aulitzky W. E., Huber C. Regulation of the cytokine network by interferon: A potential mechanism of interferon in chronic myelogenous leukemia. Sem. Hematol. 1993; 30 (3, S3) 28 – 31
21. Wetzler M., Kurzrock R., Estrov Z., Talpaz M. Altered levels of interleukin-1-beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: Clinical and prognostic correlates. Blood 1994; 84 (9) 3142 – 3147
22. Tracey K. J., Vlassara H., Cerami A. Cachectin/tumour necrosis factor. Lancet 1989; 112: 2 – 1126
23. Wilson A. G., De Vries N., Pociot F., Di-Giovine F. S., Van der Putte L. P., Duff G. W. An allelic polymorphism within the tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3. J. Exp. Med. 1993; 177 (2) 557 – 560
24. Danis V. A., Millington M., Hyland V., Lawford R., Huang Q., Grennan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis. Markers 1995; 12 (2) 127 – 133
25. Mc Guire W., Hill A. V., Allsopp C. E., Greenwood B. M., Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371 (6497) 508 – 510
26. Mayer F., Messer G., Knabe H., Mempel W., Meurer M., Kolb H. J., Holler E. High response of TNFa-secretion in vivo in patients undergoing BMT may be associated with the -308 bp TNF-a-gene enhancer polymorphism. Bone Marrow Transplantation 1996; 17: S1, S101, abstract
27. De Waal Malefyt R., Abrams J., Bennert B., Figdor C. C., De Vries J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991; 174: 1209 – 1220
28. Holler E., Roncarolo M. G., Hintermeier-Knabe R., Ertl B. Low incidence of transplant related complications in patients with high spontaneous IL-10 production prior to conditioning—evidence for a protective role of 11–10 in allogeneic BMT. Bone Marrow Transplantation 1995; 1: 5, S2, S59 (abstract)
29. Holler E., Thierfelder S., Behrends U., Daum L., Hintermeier-Knabe R., Kolb H. J., Kempeni J., Wilmanns W. Anti-TNF-alpha and pentoxifylline for prophylaxis of aGvHD in murine semiallogeneic bone marrow transplantation. Onkologie 1992; 15: 31 – 35
30. Piguet P. F., Gran G. E., Allet B., Vassalli P. J. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease. J. Exp. Med. 1987; 166: 1280 – 1289
31. Echtenacher B., Falk W., Maennel D. N., Krammer P. H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 1990; 145: 3762 – 3766
32. Clift R. A., Bianco J. A., Appelbaum F. R., Buckner C. D., Singer J. W., Bakke L., Bensinger W. I., Bowden R. A., McDonald G. B., Schubert M., Shields A. F., Slattery J. T., Storb R., Fisher L. D., Mori M., Thomas E. D., Hansen J. A. A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing bone marrow transplantation. Blood 1993; 82: 2025 – 2030
33. Behrends U., Peter R. U., Hintermeier-Knabe R., Eiβner G., Holler E., Bornkamm G. W., Caughman S. W., Degitz C. Ionizing radiation induces human intercellular adhesion molecule-1 in vitro. J. Investig. Dermatol. 1994; 103 (5) 726 – 730
34. Eissner G., Kohlhuber F., Grell M., Ueffing M., Scheurich P., Hieke A., Multhoff G., Bornkamm G. W., Holler E. Critical involvement of transmembrane TNFa in endothelial programmed cell death mediated by ionizing irradiation and bacterial endotoxin. Blood 1995; 86 (11) 4175 – 4184
35. Kolb H. J., Schattenberg A., Goldman J. M., Hertenstein N., Arcese W., Ljungman P., Ferrant A., Verdonck L., Niederwieser D., Van Rhee F., Mittermueller J., De Witte T., Holler E., Ansari H. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86 (5) 2041 – 2050